Market Tracker

12/09 5:16pm ET

Redhill Biopharma Ltd (NASDAQ:RDHL)

11.33
Delayed Data
As of Dec 09
 +0.04 / +0.35%
Today’s Change
8.10
Today|||52-Week Range
16.54
-12.03%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close11.29
Today’s open11.11
Day’s range11.05 - 11.67
Volume12,181
Average volume (3 months)38,924
Market cap$144.8M
Dividend yield--
Data as of 3:58pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-60.54%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.96%
P/E ratio--
Price/Sales47,981.20
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
VVUSVIVUS Inc-0.02-1.43%
CTICCTi Biopharma Corp+0.01+1.17%
AKAOAchaogen Inc+0.22+4.37%
NYMXNymox Pharmaceutical...-0.13-4.15%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$3.0K
Annual profit (last year)-$21.1M
Net profit margin-703,000.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Chief Operating Officer
Gilead Raday
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts